210 related articles for article (PubMed ID: 17455647)
1. [Anti-tuberculosis drugs].
Doi N
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():367-74. PubMed ID: 17455647
[No Abstract] [Full Text] [Related]
2. [Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].
Tärnvik A
Lakartidningen; 2000 Nov; 97(48):5590-2. PubMed ID: 11187373
[No Abstract] [Full Text] [Related]
3. [Sensitivity of Mycobacterium tuberculosis in our environment].
Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
[No Abstract] [Full Text] [Related]
4. [Primary resistance of Mycobacterium tuberculosis].
Barranquero Arola M; Gorritxo Gil B; Goiriena de Gandarias J
Rev Sanid Hig Publica (Madr); 1984; 58(11-12):1107-15. PubMed ID: 6443589
[No Abstract] [Full Text] [Related]
5. A review on various heterocyclic moieties and their antitubercular activity.
Sharma S; Sharma PK; Kumar N; Dudhe R
Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
[TBL] [Abstract][Full Text] [Related]
6. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Influence of background factors, factors regarding the method of treatment and the course of the disease on the emergence of drug resistance].
Yamamoto M; Nakamura H; Inagaki H
Kekkaku; 1970 Oct; 45(10):349-57. PubMed ID: 4991618
[No Abstract] [Full Text] [Related]
7. Tuberculosis drug resistance: summary report for 2003.
Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
[No Abstract] [Full Text] [Related]
8. Fighting tuberculosis: old drugs, new formulations.
Blasi P; Schoubben A; Giovagnoli S; Rossi C; Ricci M
Expert Opin Drug Deliv; 2009 Sep; 6(9):977-93. PubMed ID: 19678791
[TBL] [Abstract][Full Text] [Related]
9. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
Sacchettini JC; Rubin EJ; Freundlich JS
Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
[TBL] [Abstract][Full Text] [Related]
10. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
[TBL] [Abstract][Full Text] [Related]
11. [Resistance to antitubercular drugs in strains of Mycobacterium tuberculosis isolated in Spain].
Ausina Ruiz V; Lonca Giménez J
Rev Clin Esp; 1999 Mar; 199(3):121-5. PubMed ID: 10230288
[No Abstract] [Full Text] [Related]
12. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
Sharma A; Khuller GK; Sharma S
Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
[TBL] [Abstract][Full Text] [Related]
13. [Drug-resistance in Mycobacterium tuberculosis in Castilla y León, Spain, 2001-2005: third collaborative study].
Alberte-Castiñeiras A; Campos-Bueno A; López-Urrutia L; Alvarez-Alonso E; Megías G; Ojeda-Fernández E; López-Medrano R; Iglesias-García J; García-Carbajosa S; Pérez-Pascual P
Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):706-9. PubMed ID: 20627375
[TBL] [Abstract][Full Text] [Related]
14. Antitubercular potential of plants: a brief account of some important molecules.
Negi AS; Kumar JK; Luqman S; Saikia D; Khanuja SP
Med Res Rev; 2010 Jul; 30(4):603-45. PubMed ID: 19626592
[TBL] [Abstract][Full Text] [Related]
15. Shortening the treatment of tuberculosis.
Mitchison DA
Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
[No Abstract] [Full Text] [Related]
16. Emerging drugs for active tuberculosis.
Ginsberg AM
Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
[TBL] [Abstract][Full Text] [Related]
17. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
Matee M; Mfinanga S; Holm-Hansen C
APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
[TBL] [Abstract][Full Text] [Related]
18. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998].
Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA
Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. The increasing prevalence of resistance to antituberculosis chemotherapeutic agents: implications for global tuberculosis control.
Iseman MD; Sbarbaro JA
Curr Clin Top Infect Dis; 1992; 12():188-207. PubMed ID: 1642799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
